Naturally-occurring material is an effective disinfectant for contact lenses, study suggests

A new study suggests a naturally-occurring material is an effective disinfectant for contact lenses, worn by millions of people worldwide.

Probe Into Private Equity in Healthcare Launched

Government officials announced a joint investigation into the role of private equity and “corporate profiteering” in healthcare during an online workshop hosted by the Federal

March 7, 2024

Travere kidney drug narrowly fails confirmatory trial following FDA approval

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed. In

September 21, 2023

Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal

Will Vertex’s “pipeline-in-a-product” pay off? That’s the bet behind the company’s $4.9 billion acquisition of Alpine Immune Sciences and its mid-stage IgA nephropathy drug, which

April 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.